Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Tisell, Anders ^a   Leinhard, Olof Dahlqvist ^a   Warntjes, Jan Bertus Marcel ^a   Aalto, Anne ^a   Smedby, Örjan ^a   Landtblom, Anne Marie ^a   Lundberg, Peter ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; AGED; AMINO ACID BRAIN LEVEL; ARTICLE; BRAIN ATROPHY; BRAIN LEVEL; BRAIN REGION; CHOLINE BRAIN LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BRAIN LEVEL; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INOSITOL BRAIN LEVEL; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; THALAMUS; WHITE MATTER;

ADULT; AGED; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; FEMALE; GLUTAMIC ACID; GLUTAMINE; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84876271669     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061817     Document Type: Article

References (34)

1. Trapp BD, Ransohoff RM, Fisher E, Rudick RA, (1999) Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability. The Neuroscientist 5: 48-57.
2. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, et al. (1998) Axonal transection in the lesions of multiple sclerosis. The New England journal of medicine 338: 278-285.
3. Lassmann H, (2004) Recent neuropathological findings in MS- implications for diagnosis and therapy. Journal of neurology 251: 2-5.
4. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, et al. (1999) Cortical lesions in multiple sclerosis. Brain 122: 17-26.
5. Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, et al. (2009) Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. Journal of Neuropathology and Experimental Neurology 68: 489-502.
6. Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD, (2001) Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57: 1248-1252.
7. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of neurology 50: 121-127.
8. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of neurology 69: 292-302.
9. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of neurology 58: 840-846.
10. Barkhof F, (2002) The clinico-radiological paradox in multiple sclerosis revisited. Current opinion in neurology 15: 239-245.
11. Minneboo A, Uitdehaag BM, Jongen P, Vrenken H, Knol D, et al. (2009) Association between MRI parameters and the MS severity scale: a 12 year follow-up study. Multiple sclerosis 15: 632-637.
12. Martola J, Bergstrom J, Fredrikson S, Stawiarz L, Hillert J, et al. (2010) A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI images. Neuroradiology 52: 109-117.
13. Caramanos Z, Narayanan S, Arnold DL, (2005) 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. Brain 128: 2483-2506.
14. Vrenken H, Barkhof F, Uitdehaag BMJ, Castelijns JA, Polman CH, et al. (2005) MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magnetic Resonance in Medicine 53: 256-266.
15. Leary SM, Davie CA, Parker GJ, Stevenson VL, Wang L, et al. (1999) 1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis. Journal of neurology 246: 1023-1026.
16. Srinivasan R, (2005) Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128: 1016-1025.
17. Geurts JJ, Barkhof F, Castelijns JA, Uitdehaag BM, Polman CH, et al. (2004) Quantitative 1H-MRS of healthy human cortex, hippocampus, and thalamus: metabolite concentrations, quantification precision, and reproducibility. Journal of magnetic resonance imaging: JMRI 20: 366-371.
18. Tisell A, Dahlqvist Leinhard O, Wrantjes JBM, Lundberg P (2012) Procedure for Quantitative 1H MRS and Tissue Characterization of Human Brain Tissue Based on the Use of Quantitative MRI. Magnetic Resonance Imaging 10.1002/mrm.24554.
19. Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L, (1999) Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 53: 1698-1704.
20. Gustafsson MC, Dahlqvist O, Jaworski J, Lundberg P, Landtblom AME, (2007) Low Choline Concentrations in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans. American Journal of Neuroradiology 28: 1306-1312.
21. West J, Warntjes JB, Lundberg P, (2012) Novel whole brain segmentation and volume estimation using quantitative MRI. European Radiology 22: 998-1007.
22. Vagberg M, Lindqvist T, Ambarki K, Warntjes JB, Sundstrom P, et al. (2013) Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis. AJNR American journal of neuroradiology 34: 498-504.
23. Ernst TR, Ross Kreis BD, (1993) Absolute Quantitation of water and Metabolites in the Human Brain I. Compartments and Water. Journal of Magnetic Resonance B 102.
24. Provencher SW, (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 30: 672-679.
25. Kreis R, (2004) Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR in biomedicine 17: 361-381.
26. Matute C, Domercq M, Sanchez-Gomez MV, (2006) Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 53: 212-224.
27. Fu Y, Sun W, Shi Y, Shi R, Cheng JX, (2009) Glutamate Excitotoxicity Inflicts Paranodal Myelin Splitting and Retraction. PLoS ONE 4: e6705.
28. Vrenken H, Geurts JJ, Knol DL, Polman CH, Castelijns JA, et al. (2006) Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. AJNR American journal of neuroradiology 27: 2005-2011.
29. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD, (2002) N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Annals of neurology 51: 51-58.
30. Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, et al. (1998) Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Seminars in neurology 18: 327-336.
31. Urenjak J, Williams SR, Gadian DG, Noble M, (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. The Journal of neuroscience: the official journal of the Society for Neuroscience 13: 981-989.
32. Brand A, Richter-Landsberg C, Leibfritz D, (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Developmental neuroscience 15: 289-298.
33. Laule C, Vavasour IM, Moore GRW, Oger J, Li DKB, et al. (2004) Water content and myelin water fraction in multiple sclerosis- A T-2 relaxation study. Journal of neurology 251: 284-293.
34. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, et al. (2003) A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Archives of neurology 60: 989-994.